Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Wave Life Sciences Ltd. | 10%+ Owner | Ordinary Shares | 14M | $69.9M | $5.00 | Dec 7, 2023 | By Corporation |
Lyell Immunopharma, Inc. | 10%+ Owner | Common Stock | 30.3M | $69M | $2.28 | Jun 21, 2021 | Indirect |
CVRx, Inc. | 10%+ Owner | Common Stock | 1.01M | $18.7M | $18.55 | Jul 2, 2021 | Indirect |
Spero Therapeutics, Inc. | 10%+ Owner | Common Stock | 9.19M | $11.7M | $1.27 | Nov 7, 2022 | Indirect |
CVRx, Inc. | 10%+ Owner | Series B-2 Preferred Stock | 0 | Jul 2, 2021 | Indirect | ||
CVRx, Inc. | 10%+ Owner | Series C-2 Preferred Stock | 0 | Jul 2, 2021 | Indirect | ||
CVRx, Inc. | 10%+ Owner | Series D-2 Preferred Stock | 0 | Jul 2, 2021 | Indirect | ||
CVRx, Inc. | 10%+ Owner | Series E-2 Preferred Stock | 0 | Jul 2, 2021 | Indirect | ||
CVRx, Inc. | 10%+ Owner | Series F-2 Preferred Stock | 0 | Jul 2, 2021 | Indirect | ||
CVRx, Inc. | 10%+ Owner | Series G Preferred Stock | 0 | Jul 2, 2021 | Indirect | ||
Innoviva, Inc. | 10%+ Owner | Common Stock | 0 | $16.05 | May 20, 2021 | Indirect | |
Lyell Immunopharma, Inc. | 10%+ Owner | Series AA Preferred Stock | 0 | Jun 21, 2021 | Indirect | ||
Theravance Biopharma, Inc. | Former 10% Owner | Ordinary Shares | 0 | $10.29 | Sep 16, 2022 | By Corporation | |
Theravance Biopharma, Inc. | Former 10% Owner | Exchangeable Senior Notes due 2023 | 0 | Sep 16, 2022 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
WVE | Wave Life Sciences Ltd. | Dec 7, 2023 | 1 | $16.5M | 4 | Jan 30, 2024 | 10%+ Owner |
WVE | Wave Life Sciences Ltd. | Jan 23, 2023 | 0 | $0 | 3 | Jan 30, 2023 | 10%+ Owner |
SPRO | Spero Therapeutics, Inc. | Nov 7, 2022 | 0 | $0 | 3 | Nov 14, 2022 | 10%+ Owner |
TBPH | Theravance Biopharma, Inc. | Sep 16, 2022 | 2 | $175M | 4 | Sep 20, 2022 | Former 10% Owner |
CVRX | CVRx, Inc. | Jul 2, 2021 | 13 | $4.95M | 4 | Jul 6, 2021 | 10%+ Owner |
CVRX | CVRx, Inc. | Jun 29, 2021 | 0 | $0 | 3 | Jul 6, 2021 | 10%+ Owner |
LYEL | Lyell Immunopharma, Inc. | Jun 21, 2021 | 2 | $0 | 4 | Jun 23, 2021 | 10%+ Owner |
ME | 23andMe Holding Co. | Jun 16, 2021 | 0 | $0 | 3 | Nov 4, 2022 | 10%+ Owner |
LYEL | Lyell Immunopharma, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 17, 2021 | 10%+ Owner |
INVA | Innoviva, Inc. | May 20, 2021 | 1 | -$392M | 4 | May 24, 2021 | 10%+ Owner |